POSEIDON PHARMACEUTICALS A/S: Financial statements 2012
CVR: 26133130
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
POSEIDON PHARMACEUTICALS A/S (CVR 26133130) has filed annual accounts for 2012. In 2012, the company reported a net result of DKK 194,000. Equity in the 2012 report amounted to DKK 63,540,000. The solvency ratio was 100%.
- Profit/Loss
- DKK 194,000
- Equity
- DKK 63,540,000
- Total Assets
- DKK 63,555,000
Official annual report
Keep an eye on POSEIDON PHARMACEUTICALS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of April 13, 2012, Jørgen Drejer has left the board of directors of POSEIDON PHARMACEUTICALS A/S.
About POSEIDON PHARMACEUTICALS A/S
POSEIDON PHARMACEUTICALS A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2001. The company has been dissolved on 3 January 2017. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named THORAX ApS and KR 957 ApS. The company has 0 employees (2004). In 2015, the company reported a net result of DKK 143,000 compared with DKK 142,000 the year before. Equity in the 2015 report amounted to DKK 63,965,000.